FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3209597803> ?p ?o ?g. }

• W3209597803 abstract "Abstract Background Peripheral artery disease (PAD) is highly prevalent in patients with diabetes and associates with a high rate of limb amputation and poor prognosis. Surgical and catheter-based revascularization have failed to improve outcome in diabetic patients with PAD. Hence, a need exists to develop new treatment strategies able to promote blood vessel growth in the ischemic limb of diabetic patients. Mono-methylation of histone 3 at lysine 4 (H3K4me1) - a specific epigenetic signature induced by the methyltransferase SETD7 - favours a chromatin active and open state thus enabling the gene transcription. Purpose To investigate whether SETD7-dependent epigenetic changes modulate post-ischemic vascularization in experimental diabetes. Methodology Primary human aortic endothelial cells (HAECs) were exposed to normal glucose (NG, 5 mM) or high glucose (HG, 20 mM) concentrations for 48 hours. Unbiased gene expression profiling was performed by RNA sequencing (RNA-seq) followed by Ingenuity Pathway Analysis (IPA). In vitro angiogenic assays like migration assay & tube formation assay were performed. Pharmacological blockade of SETD7 was achieved by using the highly selective inhibitor called (R)-PFI-2. T1D mice (streptozotocin-induced diabetes) was orally treated with (R)-PFI-2 and with vehicle for 21 days and followed by induction of hindlimb ischemia. Blood flow recovery was analyzed at 30 minutes, 7 and 14 days by laser doppler imaging. Gastrocnemius muscle samples from patients with and without T2D were employed to translate our experimental findings. Results RNA-seq in HG-treated HAECs revealed a profound upregulation of the methyltransferase SETD7, an enzyme involved in mono-methylation of lysine 4 at histone 3 (H3K4me1). SETD7 upregulation in HG-treated HAECs was associated with an increase of H3K4-mono-methylation levels as well as with impaired endothelial cell migration and tube formation. Of interest, both gene silencing (SETD7-siRNA) and pharmacological blockade of SETD7 by (R)-PFI-2 rescued hyperglycemia-induced impairment of angiogenic properties in HAECs. RNA-seq in HG-treated HAECs with and without SETD7 depletion unveiled an array of differentially expressed genes, which were mainly involved in blood vessel growth and angiogenic response. Among dysregulated genes, Chromatin immunoprecipitation (ChIP) assays showed that SETD7 specifically mono-methylates H3K4m1 in proximity of Semaphorin-3G (SEMA3G) promoter, thus regulating its expression. Treatment of T1D mice with (R)-PFI-2 improved blood flow reperfusion at 14 days as compared to vehicle-treated animals. Finally, SETD7/SEMA3G axis was upregulated in muscle specimens from T2D patients. Conclusion Targeting SETD7 represents a novel epigenetic-based therapy to boost neovascularization in diabetic patients with PAD. FUNDunding Acknowledgement Type of funding sources: Public Institution(s). Main funding source(s): University of Zurich" @default.
• W3209597803 created "2021-11-08" @default.
• W3209597803 creator A5024381247 @default.
• W3209597803 creator A5031442314 @default.
• W3209597803 creator A5032257383 @default.
• W3209597803 creator A5035872503 @default.
• W3209597803 creator A5045293936 @default.
• W3209597803 creator A5050799541 @default.
• W3209597803 creator A5066702336 @default.
• W3209597803 creator A5080414144 @default.
• W3209597803 creator A5087471697 @default.
• W3209597803 date "2021-10-01" @default.
• W3209597803 modified "2023-09-23" @default.
• W3209597803 title "Pharmacological blockade of histone methyltransferase SETD7 restores angiogenic response in experimental diabetes" @default.
• W3209597803 doi "https://doi.org/10.1093/eurheartj/ehab724.3203" @default.
• W3209597803 hasPublicationYear "2021" @default.
• W3209597803 type Work @default.
• W3209597803 sameAs 3209597803 @default.
• W3209597803 citedByCount "0" @default.
• W3209597803 crossrefType "journal-article" @default.
• W3209597803 hasAuthorship W3209597803A5024381247 @default.
• W3209597803 hasAuthorship W3209597803A5031442314 @default.
• W3209597803 hasAuthorship W3209597803A5032257383 @default.
• W3209597803 hasAuthorship W3209597803A5035872503 @default.
• W3209597803 hasAuthorship W3209597803A5045293936 @default.
• W3209597803 hasAuthorship W3209597803A5050799541 @default.
• W3209597803 hasAuthorship W3209597803A5066702336 @default.
• W3209597803 hasAuthorship W3209597803A5080414144 @default.
• W3209597803 hasAuthorship W3209597803A5087471697 @default.
• W3209597803 hasConcept C104317684 @default.
• W3209597803 hasConcept C126322002 @default.
• W3209597803 hasConcept C127561419 @default.
• W3209597803 hasConcept C134018914 @default.
• W3209597803 hasConcept C16685009 @default.
• W3209597803 hasConcept C33288867 @default.
• W3209597803 hasConcept C41091548 @default.
• W3209597803 hasConcept C541997718 @default.
• W3209597803 hasConcept C55493867 @default.
• W3209597803 hasConcept C555293320 @default.
• W3209597803 hasConcept C71924100 @default.
• W3209597803 hasConcept C86803240 @default.
• W3209597803 hasConcept C91965660 @default.
• W3209597803 hasConceptScore W3209597803C104317684 @default.
• W3209597803 hasConceptScore W3209597803C126322002 @default.
• W3209597803 hasConceptScore W3209597803C127561419 @default.
• W3209597803 hasConceptScore W3209597803C134018914 @default.
• W3209597803 hasConceptScore W3209597803C16685009 @default.
• W3209597803 hasConceptScore W3209597803C33288867 @default.
• W3209597803 hasConceptScore W3209597803C41091548 @default.
• W3209597803 hasConceptScore W3209597803C541997718 @default.
• W3209597803 hasConceptScore W3209597803C55493867 @default.
• W3209597803 hasConceptScore W3209597803C555293320 @default.
• W3209597803 hasConceptScore W3209597803C71924100 @default.
• W3209597803 hasConceptScore W3209597803C86803240 @default.
• W3209597803 hasConceptScore W3209597803C91965660 @default.
• W3209597803 hasIssue "Supplement_1" @default.
• W3209597803 hasLocation W32095978031 @default.
• W3209597803 hasOpenAccess W3209597803 @default.
• W3209597803 hasPrimaryLocation W32095978031 @default.
• W3209597803 hasRelatedWork W12176262 @default.
• W3209597803 hasRelatedWork W1633404 @default.
• W3209597803 hasRelatedWork W18442815 @default.
• W3209597803 hasRelatedWork W18585590 @default.
• W3209597803 hasRelatedWork W6787283 @default.
• W3209597803 hasRelatedWork W7058128 @default.
• W3209597803 hasRelatedWork W7401494 @default.
• W3209597803 hasRelatedWork W9811100 @default.
• W3209597803 hasRelatedWork W19159343 @default.
• W3209597803 hasRelatedWork W20340699 @default.
• W3209597803 hasVolume "42" @default.
• W3209597803 isParatext "false" @default.
• W3209597803 isRetracted "false" @default.
• W3209597803 magId "3209597803" @default.
• W3209597803 workType "article" @default.